The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: gemcitabine     Quarter: 2016Q3

Total Records: 1,060     Number of Pages: 53

DRUGNAME PT EventCount
GEMCITABINE Bone pain 1
GEMCITABINE Breast cancer 1
GEMCITABINE Breast disorder 1
GEMCITABINE Breast tenderness 1
GEMCITABINE Bronchitis 1
GEMCITABINE C-reactive protein increased 1
GEMCITABINE Cachexia 1
GEMCITABINE Capillary leak syndrome 1
GEMCITABINE Carbohydrate antigen 125 increased 1
GEMCITABINE Cardiac tamponade 1
GEMCITABINE Cardio-respiratory arrest 1
GEMCITABINE Central nervous system haemorrhage 1
GEMCITABINE Central nervous system lesion 1
GEMCITABINE Change of bowel habit 1
GEMCITABINE Cholangitis infective 1
GEMCITABINE Cholecystitis acute 1
GEMCITABINE Cholestasis 1
GEMCITABINE Chronic fatigue syndrome 1
GEMCITABINE Chronic kidney disease 1
GEMCITABINE Circulatory collapse 1

Total Records: 1,060     Number of Pages: 53